PlainPharmaWatch

CMS Open Payments · Tool

Shape Memory Medical Inc. vs Calliditas Therapeutics US Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Shape Memory Medical Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 268, versus 169 for the other company. Its single largest recorded recipient represents 0.1% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Shape Memory Medical Inc.
HHI 268 · top recipient 0.1%
Ranked #1,491 of 1,838 companies by HHI
Calliditas Therapeutics US Inc.
HHI 169 · top recipient 0.1%
Ranked #1,593 of 1,838 companies by HHI

Payment Overview

Total Payments
$2.0M
% of Industry
0.0%
Transactions
379
Avg per Transaction
$5.3K
Recipients
246
Avg per Recipient
$8.1K
Payment Types
3
Top Payment Type
Food and Beverage
Total Payments
$2.0M
% of Industry
0.0%
Transactions
12,052
Avg per Transaction
$165.74
Recipients
12,051
Avg per Recipient
$165.75
Payment Types
6
Top Payment Type
Honoraria

Highlighted values indicate the higher figure for each metric.

Total payments compared

Shape Memory Medical Inc. vs Calliditas Therapeutics US Inc. - total reported payments in CMS Open Payments PY2024

Shape Memory Medical Inc.$2.0MCalliditas Therapeutics US…$2.0M

Payment Types Breakdown

Shape Memory Medical Inc.

Food and Beverage $14.3K

0.7%

Travel and Lodging $7.9K

0.4%

Consulting Fee $3.0K

0.1%

Calliditas Therapeutics US Inc.

Honoraria $878.3K

44.0%

Consulting Fee $472.9K

23.7%

Food and Beverage $353.3K

17.7%

Travel and Lodging $280.4K

14.0%

Space Rental or Facility Fees $1.5K

0.1%

Education $250.00

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Shape Memory Medical Inc.

  1. 1

    DIPANKAR MUKHERJEE

    $2,072.90 · 9 txns

  2. 2

    JAVIER VASQUEZ JR.

    $1,398.59 · 6 txns

  3. 3

    THEKLA BACHARACH

    $1,293.42 · 3 txns

  4. 4

    LAUREN A HUNTRESS

    $1,241.88 · 3 txns

  5. 5

    THOMAS FRANCIS XAVIER O'DONNELL

    $1,222.84 · 9 txns

Calliditas Therapeutics US Inc.

  1. 1

    GERALD BERNARD APPEL

    $122,899.83 · 94 txns

  2. 2

    JORGE ANTONIO LARRANAGA

    $106,250.71 · 102 txns

  3. 3

    SREEDHAR A MANDAYAM

    $74,332.61 · 97 txns

  4. 4

    ANIS A RAUF

    $69,181.56 · 80 txns

  5. 5

    SAYNA NOROUZI

    $68,439.72 · 58 txns

Summary Comparison

Metric Shape Memory Medical Inc. Calliditas Therapeutics US Inc.
Total Payments $2.0M $2.0M
% of Industry Total 0.0% 0.0%
Transaction Count 379 12,052
Avg per Transaction $5.3K $165.74
Recipient Count 246 12,051
Avg per Recipient $8.1K $165.75
Payment Type Count 3 6
Top Payment Type Food and Beverage Honoraria

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.